Abstract
Background and aims
Maturity onset diabetes in young (MODY) is a common monogenic form of diabetes with autosomal dominant type of inheritance [1] . The symptoms include early onset of diseases i.e. below 25 years of age, without insulin resistance and autoimmunity and insulin is not required at diagnosis [2] . When compared to type-2 diabetes patients, it occurs at younger ages, without overweight and with a strong family history. As compared to type-1 diabetes, the progression is less severe and insulin is required at very low dosage [3] .
There are 13 subtypes of MODY which are named with respect to involved gene. The most common form of the MODY are GCK, HNF1α and HNF4α [4] . The different types of MODY differ with respect to onset age, hyperglycemia pattern, treatment response [5] . The current consensus on diagnosis of the disease is related to phenotype guided (appearance of symptoms) screening of the most commonly prevalent genes involved in MODY [6, 7] . Genetic confirmation of the MODY and its subtype may guide regarding choice of therapy [8, 9] .
The MODY patients may be frequently misdiagnosed as having type 1 or type 2 diabetes [10]. The diagnosis of MODY has important implications for the treatment of the disease. The sulfonylurea therapy is used for the treatment of HNF1α and HNF4α MODY type as compared to insulin or metformin therapy [8, [11] [12] [13] . Another common type of MODY is GCK type has a unique phenotype of mild, non-progressive hyperglycemia, with HbA1c typically around 7% (53 mmol/mol). It is not associated with increased risk of micro vascular and macro vascular complications seen in other forms of diabetes [14] . Generally, treatment does not change HbA1c. Molecular diagnosis of GCK-MODY allows pharmacologic therapy to be discontinued and decreases the needed frequency of medical surveillance [5, 15] . MODY mutations in around twelve different genes have been reported to date mentioned in Table 1 . The most prevalent are HNF1A, GCK and HNF4A [10, 16] .
The objective was to review the common types of MODY reported in literature in context to their geographical areas.
Material and method
The countries were grouped into regions i.e. Asia, Europe, America, Africa, Australia & Oceania. For the review of literature, PubMed data base was used. The search was made in PubMed using key words "Maturity Onset diabetes of the Young".
The resulting articles search was reviewed by titles and if articles were representative of inclusion criteria, the abstract and full article (if available) were retrieved. The studies belonging to their respective countries were grouped.
The studies were included if they met following inclusion criteria i) published in English language; ii) presented original data; and iii) described type of Maturity Onset Diabetes in Young. Studies were excluded if they were of review article type, editorial.
The information related to title, primary author, year of publication, country name, and type of Maturity onset diabetes in young (MODY) were extracted. Data were recorded and compiled using Microsoft Excel.
Results
The initial search using the key term "Maturity onset diabetes of the Young" resulted in 1135 studies and after reviewing, 206 studies were selected. These studies were grouped according to their countries in the regions. There were 49 studies from Asia, 115 from Europe, 35 from America 3 from Australia and one from Africa (Table 1) . When analysing different MODY types in different regions, we came to know that among all, 59 studies have reported MODY 2 and among them most (36) were from Europe. Total of 45 studies reported MODY 3 which was also most common from Europe followed by others. Total of 19 studies reported MODY 1 ( Table 2 ).
The prevalent types of MODY were compared among the countries of the region. It reveals that MODY 3 was common in Japan and China whereas MODY 2 was common in India and Korea in Asia region. In Europe, MODY 3 was common in France, Norway and Germany while MODY 2 was in United Kingdom, Italy, Spain and Czech Republic. In America, MODY 2 was common in Canada, Brazil and Argentina while MODY 1 was prevalent in United States. (Table 3) . 
Discussion
This review summarizes the information related to prevalent types of MODY round the globe. The MODY 2 and 3 has shown to be most common in almost all the countries.
The MODY 2 is also known as GCK type. It is unique type of MODY with non-progressive hyperglycaemia and slightly elevated HbA1c (i.e. 7%). Complications (macrovascular and micro vascular) are typically not seen in case of this type of diabetes [14] . The molecular diagnosis is of utmost importance as most of the time, patients were misdiagnosed as type-1 and its treatment pattern differ from type-1 diabetes [5, 15] .
The MODY 3 is known as hepatocyte nuclear factor 1α (HNF 1α) named after the involvement of gene. Its treatment pattern is also different from other types. For these two types, the sulfonylurea therapy is used for the treatment instead of insulin or metformin therapy [8, [11] [12] [13] .
The findings from Asia was similar to those reported from United Kingdom in which MODY type 2 and type 3 was more common [17] . Conflict of interest. All the authors declare that they have no conflict of interest.
